Compare Novast vs Ology Bioservices
Customers evaluate the quality of Novast's products using the following success metrics.
Overview
Novast is 19 yrs old and is based in China.
Novast operates as a generic and specialty pharmaceutical company. It specializes in the research and development (R&D) of generic pharmaceuticals It was founded in 2005 and is based in Nantong, China.
Ology Bioservices is 25 yrs old and is based in United States.
Ology Bioservices is a privately held biopharmaceutical company with a major focus on developing a diversified proprietary pipeline of products having both biodefense and medical applications. Products under development include biodefense medical countermeasures, CNS, wound healing, addiction and pain, oncology, anti-infectives, vaccines and orthopedics. The Company has one FDA cleared injectable biologic, NanoFUSE DBM, used by orthopedic surgeons as bone graft filler. Nanotherapeutics has in-house cGMP manufacturing, formulation, and expertise in pre-clinical and clinical product development as well as clinical trial management to support its products. On April 12th, 2021, Ology Bioservices was acquired by RESILIENCE. The terms of the transaction were not disclosed.
Demo Video
Leadership
Guohua Zhang (Chief Executive Officer, President)
Brandon Brega (Chief Operating Officer)
Investors
HighLight Capital, Shiyu Capital
Resilience, U.S. Department of Defense
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Novast has not claimed their profile.
Work for Novast? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Novast?
Claim your profile now.
Information not available because Ology Bioservices has not claimed their profile.
Work for Ology Bioservices? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Ology Bioservices?
Claim your profile now.